Karen Ferrer

4.0k total citations · 1 hit paper
31 papers, 3.1k citations indexed

About

Karen Ferrer is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Karen Ferrer has authored 31 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Karen Ferrer's work include Breast Cancer Treatment Studies (7 papers), Reproductive System and Pregnancy (6 papers) and Estrogen and related hormone effects (4 papers). Karen Ferrer is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Reproductive System and Pregnancy (6 papers) and Estrogen and related hormone effects (4 papers). Karen Ferrer collaborates with scholars based in United States, Japan and Germany. Karen Ferrer's co-authors include Robert Deans, Amelia Bartholomew, Annemarie Moseley, Cord Sturgeon, Ronald Hoffman, Sheila Patil, David S. Ucker, Kevin R. McIntosh, Steve Devine and Nadim Mahmud and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Karen Ferrer

31 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

2002 1.8k citations Amelia Bartholomew, Cord Sturgeon et al. Experimental Hematology profile →

Peers

Countries citing papers authored by Karen Ferrer

Since Specialization

Citations

This map shows the geographic impact of Karen Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Ferrer more than expected).

Fields of papers citing papers by Karen Ferrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Ferrer. The network helps show where Karen Ferrer may publish in the future.

Co-authorship network of co-authors of Karen Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Ferrer. A scholar is included among the top collaborators of Karen Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Ferrer. Karen Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk Factors Associated With COVID-19 Symptoms and Potential Vertical Transmission During Pregnancy: A Retrospective Cohort Study 2022 ·Cureus ·(unknown), (unknown), Karen Ferrer, (unknown), (unknown), (unknown), (unknown)	4
2	Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Courtney M.P. Hollowell, Ximing J. Yang, Marin Sekosan, Karen Ferrer, Andre Kajdacsy‐Balla, (unknown), Maria Ruden, (unknown), Daniel P. Dalton, David D. Casalino, Rick A. Kittles, Peter H. Gann, Edward M. Schaeffer, Adam B. Murphy	7
3	Race and the Prognostic Influence of p53 in Women with Breast Cancer 2012 ·Annals of Surgical Oncology ·Keith A. Dookeran, James J. Dignam, (unknown), Karen Ferrer, Marin Sekosan, Worta McCaskill‐Stevens, Sarah Gehlert	9
4	p53 as a Marker of Prognosis in African-American Women with Breast Cancer 2010 ·Annals of Surgical Oncology ·Keith A. Dookeran, James J. Dignam, Karen Ferrer, Marin Sekosan, Worta McCaskill‐Stevens, Sarah Gehlert	43
5	Basal subtype predicts poorer prognosis in younger, but not older, African-American women with breast cancer. 2007 ·Cancer Research ·Keith A. Dookeran, (unknown), Yu Wang, Karen Ferrer, Marin Sekosan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Worta McCaskill‐Stevens, Howard A. Zaren	2
6	Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions 2007 ·The American Journal of Surgery ·Itamar Ashkenazi, Karen Ferrer, Marin Sekosan, (unknown), (unknown), (unknown), Ron Lavy, Howard A. Zaren	53
7	p53 status is more likely than basal subtype to predict survival in African-American women with breast cancer 2006 ·Clinical Cancer Research ·Keith A. Dookeran, (unknown), Yiting Wang, Karen Ferrer, Marin Sekosan, (unknown), (unknown), Rafael de la Torre, A. Jacobson, (unknown), (unknown), Howard A. Zaren, Worta McCaskill‐Stevens	1
8	Decidual Stromal Cell Response to Paracrine Signals from the Trophoblast: Amplification of Immune and Angiogenic Modulators1 2006 ·Biology of Reproduction ·A.P. Hess, Amy E. Hamilton, Saïd Talbi, Chrysoula Dosiou, Mette Nyegaard, Nihar R. Nayak, (unknown), Patricia A. Mavrogianis, Karen Ferrer, J.S. Kruessel, (unknown), S.J. Fisher, L.C. Giudice	244
9	Up-regulation of Cyclooxygenase-2 Expression and Prostaglandin Synthesis in Endometrial Stromal Cells by Malignant Endometrial Epithelial Cells 2002 ·Journal of Biological Chemistry ·Mitsutoshi Tamura, Siby Sebastian, Sijun Yang, Bilgin Gürateş, Karen Ferrer, Hironobu Sasano, Kunihiro Okamura, Serdar E. Bulun	56
10	Regulation of Aromatase P450 Expression in Endometriotic and Endometrial Stromal Cells by CCAAT/Enhancer Binding Proteins (C/EBPs): Decreased C/EBPβ in Endometriosis Is Associated with Overexpression of Aromatase 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Sijun Yang, Zongjuan Fang, Takashi Suzuki, Hironobu Sasano, Jianfeng Zhou, Bilgin Gürateş, Mitsutoshi Tamura, Karen Ferrer, Serdar E. Bulun	72
11	Cardiac papillary fibroelastoma 2002 ·European Journal of Cardio-Thoracic Surgery ·(unknown), Malek G. Massad, Sanjay Gandhi, Karen Ferrer	1
12	Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo breakdown → 2002 ·Experimental Hematology ·Amelia Bartholomew, Cord Sturgeon, (unknown), Karen Ferrer, Kevin R. McIntosh, Sheila Patil, (unknown), Steve Devine, David S. Ucker, Robert Deans, Annemarie Moseley, Ronald Hoffman	1788
13	Inflammatory myofibroblastic tumor presenting with tracheal obstruction in a pregnant woman 2002 ·American Journal of Otolaryngology ·(unknown), (unknown), Karen Ferrer, (unknown)	24
14	Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion 2001 ·Experimental Hematology ·Steven M. Devine, Amelia Bartholomew, Nadim Mahmud, Mary C. Nelson, Sheila Patil, (unknown), Cord Sturgeon, Terry A. Hewett, Theodore D. Chung, Wendy Stock, Dorie Sher, Scott M. Weissman, Karen Ferrer, Joseph D. Mosca, Robert Deans, Annemarie Moseley, Ronald Hoffman	336
15	Evaluation of Langerhans' Cells in the Cervical Epithelium of Women with Cervical Intraepithelial Neoplasia 1999 ·Gynecologic Oncology ·Joseph P. Connor, Karen Ferrer, John P. Kane, Jeffrey M. Goldberg	51
16	Histologic characteristics of laparoscopic argon beam coagulation 1998 ·The Journal of the American Association of Gynecologic Laparoscopists ·(unknown), (unknown), Karen Ferrer, (unknown), Andrew I. Brill, Bert Scoccia	18
17	Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density 1998 ·Head & Neck ·(unknown), Louis Portugal, Barry L. Wenig, Karen Ferrer, James C. Wu, (unknown)	24
18	Human Papillomavirus Expression and p53 Gene Mutations in Squamous Cell Carcinoma 1997 ·Archives of Otolaryngology - Head and Neck Surgery ·Louis Portugal, (unknown), Barry L. Wenig, Karen Ferrer, Edwardine Nodzenski, (unknown), (unknown), Ralph R. Weichselbaum, Everett E. Vokes	45
19	Expression of Epidermal Growth Factor and Androgen Receptors in Ovarian Cancer 1997 ·Gynecologic Oncology ·John Ilekis, Joseph P. Connor, Gail S. Prins, Karen Ferrer, Craig Niederberger, Bert Scoccia	69
20	Pediatric soft tissue sarcomas of nonmyogenic origin 1993 ·Journal of Surgical Oncology ·(unknown), Edward A. Levine, Karen Ferrer, Tapas K. Das Gupta	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact